These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 8936348)
1. Amyotrophic lateral sclerosis: the involvement of intracellular Ca2+ and protein kinase C. Krieger C; Lanius RA; Pelech SL; Shaw CA Trends Pharmacol Sci; 1996 Mar; 17(3):114-20. PubMed ID: 8936348 [TBL] [Abstract][Full Text] [Related]
2. A role for amplified protein kinase C activity in the pathogenesis of amyotrophic lateral sclerosis. Lanius RA; Paddon HB; Mezei M; Wagey R; Krieger C; Pelech SL; Shaw CA J Neurochem; 1995 Aug; 65(2):927-30. PubMed ID: 7616256 [TBL] [Abstract][Full Text] [Related]
3. Molecular and cellular mechanism of glutamate receptors in relation to amyotrophic lateral sclerosis. Iwasaki Y; Ikeda K; Kinoshita M Curr Drug Targets CNS Neurol Disord; 2002 Oct; 1(5):511-8. PubMed ID: 12769603 [TBL] [Abstract][Full Text] [Related]
5. ALS IgGs suppress [Ca2+]i rise through P/Q-type calcium channels in central neurones in culture. Andjus PR; Khiroug L; Nistri A; Cherubini E Neuroreport; 1996 Aug; 7(12):1914-6. PubMed ID: 8905691 [TBL] [Abstract][Full Text] [Related]
6. Loss of metabotropic glutamate receptor-mediated regulation of glutamate transport in chemically activated astrocytes in a rat model of amyotrophic lateral sclerosis. Vermeiren C; Hemptinne I; Vanhoutte N; Tilleux S; Maloteaux JM; Hermans E J Neurochem; 2006 Feb; 96(3):719-31. PubMed ID: 16371010 [TBL] [Abstract][Full Text] [Related]
7. Phosphatidylinositol 3-kinase: increased activity and protein level in amyotrophic lateral sclerosis. Wagey R; Pelech SL; Duronio V; Krieger C J Neurochem; 1998 Aug; 71(2):716-22. PubMed ID: 9681462 [TBL] [Abstract][Full Text] [Related]
8. [Death of motor neurons and molecular change of glutamate receptors in ALS]. Shin K Rinsho Shinkeigaku; 2005 Nov; 45(11):982-4. PubMed ID: 16447780 [TBL] [Abstract][Full Text] [Related]
10. Calcium dysregulation in amyotrophic lateral sclerosis. Grosskreutz J; Van Den Bosch L; Keller BU Cell Calcium; 2010 Feb; 47(2):165-74. PubMed ID: 20116097 [TBL] [Abstract][Full Text] [Related]
11. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis. Heath PR; Shaw PJ Muscle Nerve; 2002 Oct; 26(4):438-58. PubMed ID: 12362409 [TBL] [Abstract][Full Text] [Related]
12. Protein SUMOylation, an emerging pathway in amyotrophic lateral sclerosis. Dangoumau A; Veyrat-Durebex C; Blasco H; Praline J; Corcia P; Andres CR; Vourc'h P Int J Neurosci; 2013 Jun; 123(6):366-74. PubMed ID: 23289752 [TBL] [Abstract][Full Text] [Related]
13. Voltage-gated calcium channels are abnormal in cultured spinal motoneurons in the G93A-SOD1 transgenic mouse model of ALS. Chang Q; Martin LJ Neurobiol Dis; 2016 Sep; 93():78-95. PubMed ID: 27151771 [TBL] [Abstract][Full Text] [Related]
14. Increased intracellular calcium triggered by immune mechanisms in amyotrophic lateral sclerosis. Appel SH; Smith RG; Alexianu M; Siklos L; Engelhardt J; Colom LV; Stefani E Clin Neurosci; 1995-1996; 3(6):368-74. PubMed ID: 9021258 [TBL] [Abstract][Full Text] [Related]
15. Excitotoxicity and amyotrophic lateral sclerosis. Van Damme P; Dewil M; Robberecht W; Van Den Bosch L Neurodegener Dis; 2005; 2(3-4):147-59. PubMed ID: 16909020 [TBL] [Abstract][Full Text] [Related]